Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Zobair Younossi,Quentin M. Anstee,Milena Marietti,Timothy Hardy,Linda Henry,Mohammed Eslam,Jacob George,Elisabetta Bugianesi

DOI: https://doi.org/10.1038/nrgastro.2017.109

2017-09-20

Abstract:Key PointsAs a consequence of the pandemic spread of obesity, NAFLD is one of the most important causes of liver disease worldwide in adults and children, although some patients are leanGlobal prevalence of NAFLD is estimated at 24%; the highest rates are reported from South America and the Middle East, followed by Asia, the USA and EuropeThe large volume of patients sets NAFLD apart from other liver disease, meaning the major focus of clinical care is discerning those at highest risk of progressive liver diseaseBeing overweight in childhood and adolescence is associated with increased risk of NAFLD later in life; consequently, the threshold of liver-related morbidity and/or mortality is reached at a younger agePatients with NAFLD have a high risk of liver-related morbidity and mortality along with metabolic comorbidities and might place a growing strain on health-care systemsWhile awaiting effective therapies, NAFLD warrants the attention of primary-care physicians, specialists and health policy makers, starting with prevention of excessive weight gain during childhood

gastroenterology & hepatology